Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
Pasquale Paolisso(CTO Andrea Alesini), Nazzareno Galiè(Azienda USL di Bologna), Emanuela Concetta D’Angelo(Azienda USL di Bologna), Nevio Taglieri(University of Bologna), Paola Rucci(University of Bologna), Carmine Pizzi(Azienda USL di Bologna), Andrea Rinaldi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Luca Bergamaschi(Ospedale G.B. Morgagni - L.Pierantoni), Francesco Donati(University of Bologna), S Toniolo(University of Bologna), Ilenia Magnani(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Francesco Angeli(Azienda USL di Bologna), Giulia Saturi(University of Bologna), Lorenzo Bartoli(University of Bologna), Andrea Stefanizzi(University of Bologna), Anna Vittoria Mattioli(University of Modena and Reggio Emilia)
Cited by 87
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
(untitled)
|European Heart Journal|2004|1k
Risk stratification and medical therapy of pulmonary arterial hypertension
|European Respiratory Journal|2018|834
Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease
|Nutrition Metabolism and Cardiovascular Diseases|2020|546